Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Publications

Anderson, Kevin L., Michael S. Mulvihill, Paul J. Speicher, Babatunde A. Yerokun, Brian C. Gulack, Daniel P. Nussbaum, David H. Harpole, Thomas A. D’Amico, Mark F. Berry, and Matthew G. Hartwig. “Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.” Ann Thorac Surg 104, no. 4 (October 2017): 1221–30. https://doi.org/10.1016/j.athoracsur.2017.05.011.

Full Text

Fitch, Zachary W., John Z. Deng, Chi-Fu Jeffrey Yang, and Thomas A. D’Amico. “Design of interventional studies in thoracic surgery.” J Thorac Dis 9, no. 10 (October 2017): 4114–16. https://doi.org/10.21037/jtd.2017.09.04.

Full Text

Karhausen, Jörn A., Alan M. Smeltz, Igor Akushevich, Mary Cooter, Mihai V. Podgoreanu, Mark Stafford-Smith, Susan M. Martinelli, Manuel L. Fontes, and Miklos D. Kertai. “Platelet Counts and Postoperative Stroke After Coronary Artery Bypass Grafting Surgery.” Anesth Analg 125, no. 4 (October 2017): 1129–39. https://doi.org/10.1213/ANE.0000000000002187.

Full Text

Ranney, David N., Michael S. Mulvihill, Babatunde A. Yerokun, Zachary Fitch, Zhifei Sun, Chi-Fu Yang, Thomas A. D’Amico, and Matthew G. Hartwig. “Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?” Eur J Cardiothorac Surg 52, no. 3 (September 1, 2017): 543–51. https://doi.org/10.1093/ejcts/ezx132.

Full Text

Yerokun, Babatunde A., Chi-Fu Jeffrey Yang, Brian C. Gulack, Xuechan Li, Michael S. Mulvihill, Lin Gu, Xiaofei Wang, et al. “A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.” J Thorac Cardiovasc Surg 154, no. 2 (August 2017): 675-686.e4. https://doi.org/10.1016/j.jtcvs.2017.02.065.

Full Text

Anderson, Kevin L., Michael S. Mulvihill, Babatunde A. Yerokun, Paul J. Speicher, Thomas A. D’Amico, Betty C. Tong, Mark F. Berry, and Matthew G. Hartwig. “Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.” Eur J Cardiothorac Surg 52, no. 2 (August 1, 2017): 370–77. https://doi.org/10.1093/ejcts/ezx091.

Full Text

Tandberg, Daniel J., Chris R. Kelsey, Thomas A. D’Amico, Jeffrey Crawford, Junzo P. Chino, Betty C. Tong, Neal E. Ready, and Ato Wright. “Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.” Clin Lung Cancer 18, no. 4 (July 2017): e259–65. https://doi.org/10.1016/j.cllc.2016.11.008.

Full Text

Yang, Chi-Fu Jeffrey, Derek Y. Chan, Paul J. Speicher, Brian C. Gulack, Betty C. Tong, Matthew G. Hartwig, Christopher R. Kelsey, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.” Ann Thorac Surg 103, no. 6 (June 2017): 1767–72. https://doi.org/10.1016/j.athoracsur.2017.01.043.

Full Text

Pages